News

Meanwhile, an analysis of 26 trials — with a total of 164,531 participants — also published in JAMA Neurology today had similar findings, linking GLP-1 drugs to a 45% lower risk of dementia.
Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...
Published in Alzheimer’s & Dementia on Thursday, Oct. 24, the study found that semaglutide — the active ingredient in popular weight loss drugs like Ozempic and Wegovy — may be linked to ...
They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...
Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with Type 2 diabetes, according to a study published Thursday in the ...
The exact numbers depended on the type of medication patients took, but the risk of developing Alzheimer’s was up to 70 ...
Ozempic Linked to Lower Alzheimer’s Risk in People with Type 2 Diabetes Written by Nancy Schimelpfening, MS on October 25, 2024 — Fact checked by Jennifer Chesak, MSJ ...
Semaglutide, the main active ingredient in Ozempic, is linked to a lower risk of cognitive decline in a new study. The study only focused on patients with type 2 diabetes. Doctors say there may be ...
A new study found that GLP-1 medications like Ozempic can lower your risk for 42 conditions, including dementia. Here's what to know, per a neurologist.
Ozempic may lower dementia and nicotine dependence risk in people with type 2 diabetes. A recent study shows fewer cognitive deficits and lower smoking rates compared with other diabetes drugs.
Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes. Story by Berkeley Lovelace Jr. ... found that semaglutide appeared to cut the risk of dementia in people with Type 2 diabetes.
According to a study published on October 24, 2024, in the journal Alzheimer’s & Dementia, the type 2 diabetes and weight loss drug semaglutide (sold under the brand names Ozempic, Wegovy, and ...